tiprankstipranks
Advertisement
Advertisement
Clearmind Medicine completes dosing for four cohorts of CMND-100 trial
PremiumThe FlyClearmind Medicine completes dosing for four cohorts of CMND-100 trial
23d ago
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
Premium
The Fly
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
1M ago
Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan
Premium
The Fly
Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan
1M ago
Clearmind Medicine announces 1-for-10 reverse share split
PremiumThe FlyClearmind Medicine announces 1-for-10 reverse share split
2M ago
Clearmind Medicine signs new research agreement with Yissum Research Development
Premium
The Fly
Clearmind Medicine signs new research agreement with Yissum Research Development
2M ago
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
Premium
The Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
2M ago
Clearmind announces evaluation of CMND-100 for breakthrough therapy designation
PremiumThe FlyClearmind announces evaluation of CMND-100 for breakthrough therapy designation
2M ago
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
Premium
The Fly
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
3M ago
Trump Trade: President to sign order on psychedelic used for PTSD
Premium
The Fly
Trump Trade: President to sign order on psychedelic used for PTSD
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100